definiens: means, with respect to any T2 Bio Co - Marketed Prod uct, the gross amounts invoiced for sales or other dispositions of such pr oducts, less the following deductions as determined in accordance with U.S. GAAP : ( a ) customary trade, cash and quantity disc ounts ; ( b ) amounts repaid or credits or allowance s given or made for rejection, defect, recall or return of product or for retroactive price reductio ns and billing errors ; ( c ) price reductions, rebates and chargebac k provisions granted to direct and indirect customers ; ( d ) if included in the aggregate gross invo ice price of such product, sales or excise taxes, duties or other similar governmental charges ( inclu ding any tax such as a value added or similar tax, and excluding any taxes based on, or in lieu of, income ) relating to the sale of such product, as adjusted for rebat es and refunds ; ( e ) the portion of administrative fees paid during the relevant time period to group purchasing organizations or pharmaceutical benefit managers relating to such product ; ( f ) any invoiced amounts that are not colle cted by T2 Bio or its Affiliates or licensees, including bad debts ( provided that any such amounts subsequently collected shall be included in Net Sa les for the period in which collected ) ; ( g ) fees or other discounts to distributors and wholesalers ; ( h ) one - half ( 1/2 ) of the amounts actually paid by T2 Bio for licenses to Intellectual Property Rights owned by Third Parties necessary to make, use or sell the T2 Bio Co - Marketed Product n ot to exceed a maximum deduction pursuant to this clause ( h ) of three percent ( 3 % ) of the gross sale prices of the applicable T2 Bio Co - Marketed Product ; and ( i ) any other similar and customary deducti ons ( including accrued provisions ) that are consistent with U.S. GAAP, consistently applied